secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2026-08-06T00:21:23+00:00
Accession:  0001193125-26-336057
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q2 revenue up 26% to $435.4M, net income $23.6M, raises FY2026 guidance, announces $100M buyback
--------------------------------------------------------------------------------

- Revenue $435.4M (+26% YoY), net income $23.6M vs loss $3.8M.
- Adjusted EBITDA $66.0M (+94% YoY), margin 15.2% vs 9.8%.
- Clinician base 8,542 (+11% YoY), visit volumes 2.6M (+19%).
- FY2026 revenue guidance raised to $1.685-1.725B, Adjusted EBITDA $215-235M.
- Board approved new $100M share repurchase program, replacing prior $100M program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526336057/0001193125-26-336057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526336057/lfst-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-336057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer